These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35201650)

  • 21. Survey of current prophylaxis practices and bleeding characteristics of children with severe haemophilia A in US haemophilia treatment centres.
    Ragni MV; Fogarty PJ; Josephson NC; Neff AT; Raffini LJ; Kessler CM
    Haemophilia; 2012 Jan; 18(1):63-8. PubMed ID: 21539695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-world resource use and costs of haemophilia A-related bleeding.
    Shrestha A; Eldar-Lissai A; Hou N; Lakdawalla DN; Batt K
    Haemophilia; 2017 Jul; 23(4):e267-e275. PubMed ID: 28574162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pattern of bleeding in a large prospective cohort of haemophilia A patients: A three-year follow-up of the AHEAD (Advate in HaEmophilia A outcome Database) study.
    Khair K; Mazzucconi MG; Parra R; Santagostino E; Tsakiris DA; Hermans C; Oldenburg J; Spotts G; Steinitz-Trost K; Gringeri A
    Haemophilia; 2018 Jan; 24(1):85-96. PubMed ID: 29044825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desmopressin for the prevention of bleeding in percutaneous kidney biopsy: efficacy and hyponatremia.
    Lim CC; Siow B; Choo JCJ; Chawla M; Chin YM; Kee T; Lee PH; Foo M; Tan CS
    Int Urol Nephrol; 2019 Jun; 51(6):995-1004. PubMed ID: 31028561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional variation and cost implications of prescribed extended half-life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophilia.
    Croteau SE; Cheng D; Cohen AJ; Holmes CE; Malec LM; Silvey M; Thornburg CD; Wheeler AP; Kouides PA; Raffini LJ; Neufeld EJ
    Haemophilia; 2019 Jul; 25(4):668-675. PubMed ID: 30993845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Individual thrombin generation and spontaneous bleeding rate during personalized prophylaxis with Nuwiq
    Dargaud Y; Negrier C; Rusen L; Windyga J; Georgiev P; Bichler J; Solomon C; Knaub S; Lissitchkov T; Klamroth R
    Haemophilia; 2018 Jul; 24(4):619-627. PubMed ID: 29855112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemophilia in Côte d'Ivoire (the Ivory Coast) in 2017: Extensive data collection as part of the World Federation of Hemophilia's twinning programme.
    Lambert C; Meité N; Sanogo I; Lobet S; Adjambri E; Eeckhoudt S; Hermans C
    Haemophilia; 2019 Mar; 25(2):236-243. PubMed ID: 30748057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1-Deamino-8-D-arginine-vasopressin--an alternative in the management of mild haemophilia A and von Willebrand's disease.
    Niessner H; Korninger C
    Wien Klin Wochenschr; 1983 Nov; 95(21):753-7. PubMed ID: 6424339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the effectiveness of DDAVP in surgery and in bleeding episodes in haemophilia and von Willebrand's disease. A study on 43 patients.
    Mariana G; Ciavarella N; Mazzucconi MG; Antoncecchi S; Solinas S; Ranieri P; Pettini P; Agrestini F; Mandelli F
    Clin Lab Haematol; 1984; 6(3):229-38. PubMed ID: 6440729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose tertiary prophylactic therapy reduces total number of bleeds and improves the ability to perform activities of daily living in adults with severe haemophilia A: a single-centre experience from Beijing.
    Hua B; Lian X; Li K; Lee A; Poon MC; Zhao Y
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):136-40. PubMed ID: 26258677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preference of treatment characteristics among people with haemophilia or their caregivers, and physicians in the Japanese healthcare environment.
    Fujii T; Ishimura M; Takao S; Deguchi A
    Haemophilia; 2024 Jul; 30(4):914-924. PubMed ID: 38695524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of joint damage in hemophilic children with early prophylaxis].
    Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
    Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desmopressin in non-severe haemophilia A: Test-response and clinical outcomes in a single Canadian centre review.
    Hews-Girard J; Rydz N; Lee A; Goodyear MD; Poon MC
    Haemophilia; 2018 Sep; 24(5):720-725. PubMed ID: 30004154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Objective quantification of adherence to prophylaxis in haemophilia patients aged 12 to 25years and its potential association with bleeding episodes.
    Pérez-Robles T; Romero-Garrido JA; Rodriguez-Merchan EC; Herrero-Ambrosio A
    Thromb Res; 2016 Jul; 143():22-7. PubMed ID: 27172834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mild bleeding disorders: review of 120 patients.
    Bolton-Maggs P; Wilkinson LS
    Clin Lab Haematol; 1984; 6(3):247-56. PubMed ID: 6335071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
    Aus G
    Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haematuria is not a risk factor of hypertension or renal impairment in patients with haemophilia.
    Sun HL; Yang M; Sait AS; von Drygalski A; Jackson S
    Haemophilia; 2016 Jul; 22(4):549-55. PubMed ID: 27030081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The natural history of mild haemophilia: a 30-year single centre experience.
    Tagliaferri A; Di Perna C; Riccardi F; Pattacini C; Rivolta GF; Franchini M
    Haemophilia; 2012 Mar; 18(2):166-74. PubMed ID: 21771207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. When should prophylactic treatment in patients with haemophilia A and B start?--The German experience.
    Kreuz W; Escuriola-Ettingshausen C; Funk M; Schmidt H; Kornhuber B
    Haemophilia; 1998 Jul; 4(4):413-7. PubMed ID: 9873763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status of haemophilia inhibitor management in mainland China: a haemophilia treatment centres survey on treatment preferences and real-world clinical practices.
    Liu W; Xue F; Poon MC; Chen L; Jin Z; Zhang L; Yang R
    Br J Haematol; 2021 Aug; 194(4):750-758. PubMed ID: 34340252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.